Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06312722 · ClinicalTrials.gov registry record · NA

Safety and Effectiveness of the Optilume® BPH Catheter System in a Post-Market Study

A NA study of Benign Prostatic Hyperplasia, sponsored by Urotronic.

Recruiting
Registry status
NA
Development phase
92
Enrollment target
5
Study locations

NCT06312722 is a NA study of Benign Prostatic Hyperplasia that is actively recruiting participants, run by Urotronic. The registered enrollment target is 92 participants, below the 549-participant average among 29 other Benign Prostatic Hyperplasia trials with a reported enrollment target (83% lower). The trial reports 5 study locations across 5 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06312722, a NA study of Benign Prostatic Hyperplasia, is actively recruiting participants, sponsored by Urotronic.

RECRUITING
Registry status
NA
Development phase
92 participants
Enrollment target
5
Study locations

Study Summary

The goal of this clinical trial is to verify the continued safety and effectiveness for the Optilume BPH Catheter System.

Conditions Studied

Benign Prostatic Hyperplasia

Interventions

  • DEVICE Optilume® BPH Catheter System

Study Locations (5)

Arkansas

  • Arkansas Urology - Little Rock

Florida

  • Florida Urology Partners, LLP - Tampa

Louisiana

  • Ochsner LSU Health Shreveport - Regional Urology - Shreveport

Nevada

  • Sheldon Freedman MD, Ltd - Las Vegas

Texas

  • Midtown Urology Associates - Austin

Trial Details

FieldValue
Enrollment Target 92 participants
Start Date 2024-02-07
Est. Completion 2031-02-07
Phase NA

Sponsor

Urotronic

8 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT06312722

The ClinicalTrials.gov registry entry for NCT06312722 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 92 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 549-participant average among 29 other Benign Prostatic Hyperplasia trials with a reported enrollment target (83% lower). The listed sponsor is Urotronic, which has 8 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Benign Prostatic Hyperplasia appearing as the primary indexed condition, and to 1 intervention - of which Optilume® BPH Catheter System is the first listed.

NCT06312722 reports 5 study locations spanning 5 distinct geographic areas - top geographies include Arkansas, Florida, Louisiana.

Frequently Asked Questions

What is clinical trial NCT06312722 about?

NCT06312722 is a clinical study titled "Safety and Effectiveness of the Optilume® BPH Catheter System in a Post-Market Study". The goal of this clinical trial is to verify the continued safety and effectiveness for the Optilume BPH Catheter System.

What is the current status of trial NCT06312722?

This trial is currently recruiting. It is a NA study. The enrollment target is 92 participants. The study started on 2024-02-07. Estimated completion is 2031-02-07.

What conditions does trial NCT06312722 study?

This clinical trial studies the following conditions: Benign Prostatic Hyperplasia.

What interventions are being tested in trial NCT06312722?

The interventions under investigation include: Optilume® BPH Catheter System (DEVICE).

Who is sponsoring clinical trial NCT06312722?

This trial is sponsored by Urotronic, which has 8 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06312722 being conducted?

This trial has 5 study locations across Arkansas, Florida, Louisiana, Nevada, Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Benign Prostatic Hyperplasia

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Benign Prostatic Hyperplasia

All registered trials for this condition

Arkansas

All trials with a study site in Arkansas

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.